We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

How Safe Are These 5%-plus Yields? GlaxoSmithKline plc, HSBC Holdings plc, Royal Dutch Shell Plc, SSE plc And Standard Chartered PLC

Yields aren’t guaranteed, which is a worry for investors in GlaxoSmithKline (LON: GSK), HSBC Holdings (LON: HSBA), Royal Dutch Shell (LON: RDSB), SSE plc (LON: SSE) And Standard Chartered PLC (LON: STAN)

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Plenty of FTSE 100 companies offer sky-high dividend yields right now of up to 6% or 7%, but these heady returns are often a sign of trouble and leaves them vulnerable to a cut.

Last year, Tesco trashed its dividend by 75%, and WM Morrison announced a 63% cut in March. Here are five FTSE 100 favourites on juicy yields, but will their pips also start to squeak?

Should you buy HSBC Holdings shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Glaxo could go

GlaxoSmithKline (LSE: GSK) currently yields 6.08%, an incredible return from one of the most solid UK dividend payers. There were no signs of dividend concerns in its recent half-yearly report, with 19p declared for Q2, and continued expectation of a full-year dividend of 80p. Management also intends to pay 80p in 2016 and 2017 as well.

Glaxo also plans to hand shareholders approximately £1 billion, or 20p per share, via a special dividend to be paid alongside its Q4 2015 ordinary dividend payment. Management generosity should be a good sign, but there are concerns. The dividend is covered just 1.2 times, which is pretty thin. Another worry is that free cash flow has taken a temporary knock this year, following the disposals of Glaxo’s oncology business and Aspen investments. The dividend looks safe for now, but could come under question if Glaxo’s sales falter.

HSBC holding on

HSBC Holdings (LSE: HSBA) yields an even more generous 6.20%, helped by a 20% drop in its share price over the last 12 months. Better still, this is covered at least 1.6 times in each of the next three years and its balance sheet looks strong too. In the short run, continuing Chinese easing should sustain HSBC, which earns 70% of its profits from the region. But if China does crash into a hard landing, HSBC’s dividend investors could get burned. 

Royal Dutch shells out

Royal Dutch Shell (LSE: RDS) is wedded to its dividend, which, unlike BP, it hasn’t cut since the Second World War. No manager will want to be the first to break that record, but with the share price down 35% in the last year, forcing the yield up to 7.14%, somebody might have to bite the bullet. Right now, it is covered 1.6 times, but City analysts reckon that will shrink to as little as 1.1 times, which is starting to look threadbare. The good news is that Shell continues to pump out the cash and management is committed to paying this year’s full-year $1.88 divi into 2016 at least. Thereafter, it all depends on the oil price.

Our friend electric

SSE (LSE: SSE) has lifted its dividend every year since 1992, at a compound annual rate of 10%, but maintaining this proud record could be getting harder as profits come under pressure, notably in its non-regulated wholesale and retail arms. Earnings per share look set to fall to 115p this year, down from 124.1p, and cash flow will be knocked by its obligations to invest in UK infrastructure.

SSE aims for 1.5 times dividend cover but that is slipping perilously towards 1.2. Cost savings and asset sell-offs may protect it for a while, but it needs to get on with the hard work of boosting earnings. Today’s 6.06% is electric, but could quickly lose its sizzle.

Standard trouble

Standard Chartered (LSE: STAN) is another FTSE 100 company forced to bite the dividend bullet, along with Tesco and WMR Morrison. In August, plunging profits force management to slash the yield in half, leaving it on a forecast 4.4%. At least that will be covered two times, giving more security going forwards. Standard Chartered may offer the lowest yield of these five stocks, but at least it is safe… for now.

Harvey Jones has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline and HSBC Holdings. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young female couple boarding their plane at the airport to go on holiday.
Investing Articles

Can the Rolls-Royce share price reach £15.97 by the end of August?

The Rolls-Royce share price has had a solid run in the last year. Muhammad Cheema takes a look at whether…

Read more »

Santa Clara offices of NVIDIA
Investing Articles

Up 1,200% in 5 years, here’s why Nvidia could still be a brilliant value stock

An exciting new announcement that could reshape the PC industry has just pushed Nvidia stock... well, just about nowhere really.

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

How investing £4.50 a day could set you on the way to a £1,505 monthly second income

How can UK stocks with high dividend yields help investors earn a meaningful second income from the price of a…

Read more »

Investing Articles

Up 103% with a P/E of 261 — is this FTSE 100 stock still worth buying?

One FTSE 100 stock is quietly moving higher while most investors are still looking elsewhere — is the market missing…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

The smart money thinks AI stocks look risky — but is there still a chance to buy?

According to fund managers, the AI trade is getting crowded. But they still seem to think it’s the place to…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

Barclays shares are 11% below their 52-week high. Could they be a bit of a bargain to consider?

Overpriced or one of the FTSE 100’s hidden gems? James Beard takes a closer look at how the market is…

Read more »

Stack of one pound coins falling over
Investing Articles

Down 65% but yielding 6.7% – is this beaten-down UK stock now a generational bargain?

Harvey Jones says this UK stock is one of the worst FTSE 100 performers but there are sound reasons to…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Is this FTSE stock really 46% undervalued?

Analysts reckon this FTSE stock should be worth nearly 50% more. James Beard considers why there’s so much positivity surrounding…

Read more »